Clinical trial
Study Of The Efficacy And Safety Of Pregabalin Compared To Placebo For Treatment…
NCT00468845 · Pfizer's Upjohn has merged with Mylan to form Viatris Inc., Industry · Completed
Key facts
| NCT number | NCT00468845 |
|---|---|
| Title | Study Of The Efficacy And Safety Of Pregabalin Compared To Placebo For Treatment Of Post-Surgical Pain From Hysterectomy |
| Official title | A Multiple Dose, Randomized, Double-Blind Multicenter Study Of The Efficacy And Safety Of Pregabalin Compared To Placebo In The Treatment Of Patients With Post-Surgical Pain From Hysterectomy |
| Lead sponsor | Pfizer's Upjohn has merged with Mylan to form Viatris Inc., Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Pain, Postoperative |
| Intervention type | Drug |
| Interventions | pregabalin (Lyrica), matched placebo |
| Enrollment | 501 |
| Start date | Jun 1, 2007 |
| Primary completion | May 1, 2010 |
| Completion | Oct 1, 2010 |
| First posted | May 3, 2007 |
| Last update posted | Feb 10, 2021 |
| Countries | Canada, Czechia, Hong Kong, South Africa, Spain, Sweden, Thailand, United Kingdom, United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: